Tag: Phase III Trial

Peanut Allergy Therapy

Aimmune, Regeneron and Sanofi Collaborate on Combination Peanut Therapy

More exciting news as pharma companies work to extend the effectiveness of their therapies in combination.
Paliforzia (AR101)

Aimmune Begins Patient Enrollment for Phase III Clinical Trial of Peanut...

First of 440 patients enrolled in study of AR101.
Viaskin Peanut

Peanut Patch Phase III Enrollment Ends, Results Expected Toward End of...

The study received higher-than-expected patient demand.